Low-dose colestipol plus probucol for hypercholesterolemia

This publication has 15 references indexed in Scilit:

• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat
  Atherosclerosis, 1981
• Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
  New England Journal of Medicine, 1981
• Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia
  Metabolism, 1980
• Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
  New England Journal of Medicine, 1980
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
  Heart, 1978
• A two-year crossover therapeutic trial with halofenate and clofibrate
  The Lancet Healthy Longevity, 1976
• Colestipol and clofibrate in hypercholesterolemia
  Clinical Pharmacology & Therapeutics, 1974
• Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
  Journal of Clinical Investigation, 1973
• Toxicity of [4,4′-(isopropylidenedithio)bis(2,6-di-t-butylphenol)], probucol, in mice, rats, dogs and monkeys: Demonstration of a species-specific phenomenon
  Toxicology and Applied Pharmacology, 1973